InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

Current share price for ACL : $2.960 0.02 (0.67%)+

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$552 Ceasing to be a substantial holder 22 Nov 2022 4:57PM $3.350 $2.960 fallen by 11.64%
$552 Becoming a substantial holder 11 Nov 2022 5:05PM $3.580 $2.960 fallen by 17.32%
$552 Medlab Pathology Cyber Incident 27 Oct 2022 8:15AM $3.540 $2.960 fallen by 16.38%
$552 2022 AGM - Results of Meeting 19 Oct 2022 11:32AM $3.460 $2.960 fallen by 14.45%
$552 2022 AGM - addresses to shareholders 19 Oct 2022 9:47AM $3.450 $2.960 fallen by 14.20%
$552 Change of Director's Interest Notice 7 Oct 2022 3:45PM $3.710 $2.960 fallen by 20.22%
$552 Director Appointment/Resignation 7 Oct 2022 3:44PM $3.710 $2.960 fallen by 20.22%
$552 Change of Director's Interest Notice 27 Sep 2022 11:51AM $3.525 $2.960 fallen by 16.03%
$552 Change of Director's Interest Notice 20 Sep 2022 10:37AM $3.800 $2.960 fallen by 22.11%
$552 Ceasing to be a substantial shareholder 16 Sep 2022 10:37AM $3.880 $2.960 fallen by 23.71%
$552 2022 Annual Report and Corporate Governance Statement 16 Sep 2022 8:24AM $3.880 $2.960 fallen by 23.71%
$552 Appendix 4G 16 Sep 2022 8:24AM $3.880 $2.960 fallen by 23.71%
$552 Notice of Annual General Meeting/Proxy Form 16 Sep 2022 8:23AM $3.880 $2.960 fallen by 23.71%
$552 Change of Director's Interest Notice 13 Sep 2022 9:01AM $4.330 $2.960 fallen by 31.64%
$552 Inclusion in S&P/ASX 300 7 Sep 2022 9:54AM $4.120 $2.960 fallen by 28.16%
$552 Change in substantial holding 5 Sep 2022 4:51PM $4.110 $2.960 fallen by 27.98%
$552 Update - Dividend/Distribution - ACL 5 Sep 2022 3:12PM $4.115 $2.960 fallen by 28.07%
$552 S&P DJI Announces September 2022 Quarterly Rebalance 2 Sep 2022 5:01PM $4.200 $2.960 fallen by 29.52%
$552 Change in substantial holding 26 Aug 2022 6:09PM $4.290 $2.960 fallen by 31%
$552 2022 AGM - Change of Date 22 Aug 2022 4:09PM $4.770 $2.960 fallen by 37.95%
$552 Ceasing to be a substantial holder 22 Aug 2022 7:49AM $4.680 $2.960 fallen by 36.75%
$552 Change in substantial holding 17 Aug 2022 9:40AM $4.790 $2.960 fallen by 38.20%
$552 Becoming a substantial holder 17 Aug 2022 8:09AM $4.790 $2.960 fallen by 38.20%
$552 Becoming a substantial holder 16 Aug 2022 3:14PM $4.770 $2.960 fallen by 37.95%
$552 Ceasing to be a substantial holder 15 Aug 2022 4:45PM $4.870 $2.960 fallen by 39.22%

576 - 600 of 1030 results

Page 24 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.